Close Menu

In the Pipeline's Derek Lowe talks about the occasional "perverse incentives" in oncology drug development. Lowe references an article from 2007 in the Journal of Clinical Oncology written by an investor, Tony Fiorino, who talks about the motives behind oncology research at large pharmaceutical companies versus small biotech start-ups.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.